ZIVO Bioscience, Inc. (ZIVOW) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Bloomfield Hills, MI, 美国. 现任CEO为 John Bernard Payne.
ZIVOW 拥有 IPO日期为 2003-12-15, 7 名全职员工, 在 NASDAQ Capital Marke, 市值为 $164.23K.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
